Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interest of Adjuvant Chemotherapy in Patients With CINSARC High-risk Localized Resected Uterine Leiomyosarcoma - Sarcome 15

NCT06524583 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT06524583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06524583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interest of Adjuvant Chemotherapy in Patients With CINSARC High-risk Localized Resected Uterine Leiomyosarcoma - Sarcome 15
Lead sponsor
UNICANCER
Phase
Phase 2
Overall status
Recruiting
Start date
January 27, 2025
Completion date
December 31, 2030
Enrollment
198 (estimated)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

leiomyosarcoma uterus